Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $12.41M in the quarter ending March 31, 2026, a decrease of -32.74%. This brings the company's revenue in the last twelve months to $56.60M, down -14.04% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

• Revenue (ttm): $56.60M
• Revenue Growth: -14.04%
• P/S Ratio: 0.41
• Revenue / Employee: $681,916
• Employees: 83
• Market Cap: 23.18M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	66.38M	1.20M	1.84%
Jun 30, 2024	65.18M	-42.22M	-39.31%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	-	-
Jun 30, 2019	-	-	-
Jun 30, 2018	3.66M	-2.78M	-43.19%
Jun 30, 2017	6.44M	-	-
Jun 30, 2016	-	-	-
Jun 30, 2015	261.78K	260.78K	26,078.20%
Aug 31, 2014	1,000.00	-57.93K	-98.30%
Jun 30, 2014	58.93K	57.18K	3,267.37%
Aug 31, 2013	1.75K	-48.25K	-96.50%
Jun 30, 2013	50.00K	48.25K	2,757.14%
Aug 31, 2012	1.75K	-	-
Aug 31, 2011	-	-	-
Aug 31, 2010	-	-	-
Aug 31, 2009	1.75K	-	-
Aug 31, 2008	-	-	-
Aug 31, 2007	-	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error